X
Ablynx drug fails in mid-stage lupus trial
https://pharmaphorum.com/news/ablynxs-vobarilizumab-fails-mid-stage-lupus-trial/
Ablynx
Novo Nordisk undeterred after losing out on Ablynx takeover
After losing out to Sanofi in its pursuit of Belgian biotech Ablynx earlier this week, Novo Nordisk has put a brave face on the disappointment.
After more encouraging data, Ablynx to file first drug with FDA
New trial data will be included in US and EU filings
Ablynx soars after blood clot trial success
European regulators are already reviewing caplacizumab
Ablynx and Sanofi sign potential 2.4bn euro R&D deal
Collaboration will develop drugs for inflammatory diseases
Ablynx files blood disorder drug in EU
Caplacizumab could be biotech’s first marketed drug.
1 2
